etanidazole and pr-104

etanidazole has been researched along with pr-104 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abbattista, MR; Ackerley, DF; Ashoorzadeh, A; Biemans, R; Copp, JN; Dubois, LJ; Guise, CP; Lambin, P; Lieuwes, NG; Mowday, AM; Patterson, AV; Smaill, JB; Syddall, SP; Theys, J; Wang, J; Williams, EM	1

Other Studies

1 other study(ies) available for etanidazole and pr-104

Article	Year
Theranostics, 2020, Volume: 10, Issue:23 Topics: Animals; Antineoplastic Agents, Alkylating; Drug Resistance, Neoplasm; Escherichia coli Proteins; Etanidazole; Genes, Reporter; Genetic Therapy; Genetic Vectors; HCT116 Cells; Humans; Hydrocarbons, Fluorinated; Imidazoles; Indicators and Reagents; Mice; Molecular Imaging; Neoplasms; Nitrogen Mustard Compounds; Nitroreductases; Positron-Emission Tomography; Precision Medicine; Proof of Concept Study; Radiopharmaceuticals; Recombinant Proteins; Triazoles; Tumor Hypoxia; Xenograft Model Antitumor Assays	2020

Article

Year

Theranostics, 2020, Volume: 10, Issue:23

Topics: Animals; Antineoplastic Agents, Alkylating; Drug Resistance, Neoplasm; Escherichia coli Proteins; Etanidazole; Genes, Reporter; Genetic Therapy; Genetic Vectors; HCT116 Cells; Humans; Hydrocarbons, Fluorinated; Imidazoles; Indicators and Reagents; Mice; Molecular Imaging; Neoplasms; Nitrogen Mustard Compounds; Nitroreductases; Positron-Emission Tomography; Precision Medicine; Proof of Concept Study; Radiopharmaceuticals; Recombinant Proteins; Triazoles; Tumor Hypoxia; Xenograft Model Antitumor Assays

2020